Divamics Inc. is an interdisciplinary biopharmaceutical company based in Suzhou, with a branch office in Beijing, focusing on drug development empowered by artificial intelligence, quantum mechanics, and molecular simulation algorithms. The company has built a next-generation AI drug discovery platform based on multiscale molecular dynamics combined with independently developed AI algorithms. It provides various computational chemistry services, including but not limited to high-flexibility target modeling, target druggability analysis, structure screening, design, and optimization for both macromolecules and small molecule drugs. Particularly, it offers molecular drugability mechanism analysis, novel drug molecule structure design, and structural optimization solutions for challenging drug targets. Its core technology has been endorsed by Nobel laureate Roald Hoffmann. Since its establishment, Divamics Inc. has provided drug development services to over 20 biopharmaceutical companies worldwide and has achieved multiple breakthroughs.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 星湖街328号, 创意产业园11-301,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.divamicsbio.com/
- HQ
- 苏州, 江苏
Divamics Inc. Questions
Divamics Inc.'s website is https://www.divamicsbio.com/
Divamics Inc.'s LinkedIn profile is https://cn.linkedin.com/company/divamics
Divamics Inc. has
6 employees.
View email and phone details for 6
employees at Divamics Inc..
Divamics Inc.'s industry is
Biotechnology Research
Divamics Inc.'s top competitors are
Peking University,
Powercomputers,
Wecomput Technology,
Shanghai Vitalgen Biopharma Co., Ltd.,
Biosimax Lifesciences Ltd,
Xtalpi Inc.,
Tech On Hand,
Xdcs,
Gel Coat Biomaterials, Inc.,
Servbus Technology (Beijing) Co., Ltd.
Divamics Inc.'s categories are Biotechnology Research
Divamics Inc.'s founding year is 2021
